1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Nicotine Addiction Global Clinical Trials Review, H1, 2015

Nicotine Addiction Global Clinical Trials Review, H1, 2015

  • February 2015
  • -
  • Global Data
  • -
  • 81 pages

Nicotine Addiction Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Nicotine Addiction Global Clinical Trials Review, H1, 2015" provides data on the Nicotine Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nicotine Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nicotine Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Nicotine Addiction Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Nicotine Addiction 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Nicotine Addiction to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Nicotine Addiction to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Nicotine Addiction 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Nicotine Addiction Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Johnson and Johnson 34
Clinical Trial Overview of Johnson and Johnson 34
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Nabi Biopharmaceuticals (Inactive) 39
Clinical Trial Overview of Nabi Biopharmaceuticals (Inactive) 39
Omeros Corporation 40
Clinical Trial Overview of Omeros Corporation 40
Star Scientific, Inc. 41
Clinical Trial Overview of Star Scientific, Inc. 41
Rock Creek Pharmaceuticals INC 42
Clinical Trial Overview of Rock Creek Pharmaceuticals INC 42
FORUM Pharmaceuticals Inc. 43
Clinical Trial Overview of FORUM Pharmaceuticals Inc. 43
Bioprojet SCR 44
Clinical Trial Overview of Bioprojet SCR 44
Clinical Trial Overview of Top Institutes / Government 45
National Institute on Drug Abuse 45
Clinical Trial Overview of National Institute on Drug Abuse 45
University of Pennsylvania 47
Clinical Trial Overview of University of Pennsylvania 47
Yale University 49
Clinical Trial Overview of Yale University 49
Mayo Clinic 50
Clinical Trial Overview of Mayo Clinic 50
Centre for Addiction and Mental Health 51
Clinical Trial Overview of Centre for Addiction and Mental Health 51
University of Wisconsin Madison 52
Clinical Trial Overview of University of Wisconsin Madison 52
Mclean Hospital 53
Clinical Trial Overview of Mclean Hospital 53
Massachusetts General Hospital 54
Clinical Trial Overview of Massachusetts General Hospital 54
Duke University 55
Clinical Trial Overview of Duke University 55
University of California, San Francisco 56
Clinical Trial Overview of University of California, San Francisco 56
Five Key Clinical Profiles 57
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81

List of Tables

Nicotine Addiction Therapeutics, Global, Clinical Trials by Region, 2015* 7
Nicotine Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Nicotine Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Nicotine Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Nicotine Addiction Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Nicotine Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Nicotine Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Nicotine Addiction Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Nicotine Addiction Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Nicotine Addiction Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Nicotine Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 34
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 36
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 38
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Nabi Biopharmaceuticals (Inactive), 2015* 39
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Omeros Corporation, 2015* 40
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Star Scientific, Inc., 2015* 41
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Rock Creek Pharmaceuticals INC, 2015* 42
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by FORUM Pharmaceuticals Inc., 2015* 43
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioprojet SCR, 2015* 44
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Drug Abuse, 2015* 45
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2015* 47
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2015* 49
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 50
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for Addiction and Mental Health, 2015* 51
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2015* 52
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2015* 53
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 54
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 55
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 56

List of Figures

Nicotine Addiction Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Nicotine Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Nicotine Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Nicotine Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Nicotine Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Nicotine Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.